Cargando…
Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer
Ovarian cancer (OC) accounts for more than 150,000 deaths worldwide every year. Patients are often diagnosed at an advanced stage with metastatic dissemination. Although platinum- and taxane-based chemotherapies are effective treatment options, they are rarely curative and eventually, the disease wi...
Autores principales: | Abildgaard, Cecilie, Do Canto, Luisa M., Steffensen, Karina D., Rogatto, Silvia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985280/ https://www.ncbi.nlm.nih.gov/pubmed/32039022 http://dx.doi.org/10.3389/fonc.2019.01549 |
Ejemplares similares
-
The Long Non-Coding RNA SNHG12 as a Mediator of Carboplatin Resistance in Ovarian Cancer via Epigenetic Mechanisms
por: Abildgaard, Cecilie, et al.
Publicado: (2022) -
The Interplay between Long Noncoding RNAs and Proteins of the Epigenetic Machinery in Ovarian Cancer
por: Calanca, Naiade, et al.
Publicado: (2020) -
Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer
por: Carvalho, Robson Francisco, et al.
Publicado: (2022) -
Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer
por: Shao, Yang, et al.
Publicado: (2018) -
The Role of Long Non-coding RNAs in Immunotherapy Resistance
por: Zhou, Yuwen, et al.
Publicado: (2019)